Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1389.8000 58.10 (4.36%)
NSE Jun 30, 2025 15:31 PM
Volume: 335.0K
 

logo
Ipca Laboratories Ltd.
30 May 2019, 12:00AM
1389.80
4.36%
Motilal Oswal
Gross margin expanded 45bp YoY to 68% due to a better product mix. Reduced remediation cost (INR40m v/s INR100m in 4QFY18) and better operating leverage led to lower other expenses (-520bp YoY). As a result, EBITDA margin expanded at an even higher rate of 590bp YoY to 20.9% (our estimate: 17.4%). EBITDA was up 49% YoY at INR1.7b (our estimate: INR1.5b), while PAT increased 71% YoY to INR1b (our estimate: INR873m)....
Ipca Laboratories Ltd. is trading below all available SMAs
More from Ipca Laboratories Ltd.
Recommended